CLINDAMYCIN PHOSPHATE TOPICAL

CLINDAMYCIN PHOSPHATE TOPICAL was reported 3566 times

CLINDAMYCIN PHOSPHATE TOPICAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYSTEMIC VIRAL INFECTION 3 0.2143
1 HIV ASSOCIATED NEPHROPATHY 3 0.0588
2 ANTIBIOTIC LEVEL BELOW THERAPEUTIC 5 0.0490
3 ANGIOMYOLIPOMA 8 0.0374
4 SINOBRONCHITIS 4 0.0268
5 OVERGROWTH BACTERIAL 5 0.0186
6 PRODUCT WITH QUALITY ISSUE ADMINISTERED 8 0.0179
7 ANORECTAL SWELLING 4 0.0175
8 GASTROINTESTINAL MUCOSA HYPERAEMIA 5 0.0169
9 VENOUS HAEMORRHAGE 5 0.0161
10 PROTEIN S DEFICIENCY 3 0.0152
11 SEVERE CUTANEOUS ADVERSE REACTION 3 0.0126
12 TUBO-OVARIAN ABSCESS 3 0.0123
13 CONGENITAL HYDROCEPHALUS 6 0.0118
14 TRACHEAL HAEMORRHAGE 4 0.0114
15 NASAL SEPTUM DISORDER 3 0.0113
16 COAGULATION FACTOR DECREASED 3 0.0110
17 MENINGOMYELOCELE 6 0.0100
18 BIOPSY LIVER 4 0.0097
19 VULVOVAGINAL INFLAMMATION 4 0.0087
20 TOXIC SHOCK SYNDROME 5 0.0079
21 POLYCYSTIC OVARIAN SYNDROME 3 0.0078
22 ENZYME LEVEL INCREASED 6 0.0071
23 HIDRADENITIS 64 0.0070
24 POUCHITIS 6 0.0070
25 CONGESTIVE HEPATOPATHY 3 0.0067
26 TRACHEITIS 5 0.0066
27 BLADDER DISCOMFORT 8 0.0064
28 ANAL INFLAMMATION 4 0.0063
29 ANAL ULCER 5 0.0061
30 FOREIGN BODY ASPIRATION 4 0.0055
31 HYPERTENSIVE URGENCY 3 0.0054
32 LYMPHOCYTE STIMULATION TEST POSITIVE 4 0.0050
33 MUSCLE ABSCESS 3 0.0048
34 ALLERGIC SINUSITIS 4 0.0047
35 OROPHARYNGEAL CANDIDIASIS 4 0.0044
36 PSEUDOMEMBRANOUS COLITIS 9 0.0040
37 PRODUCT CONTAINER SEAL ISSUE 7 0.0040
38 APPLICATION SITE DISCOMFORT 7 0.0039
39 CALCIUM DEFICIENCY 5 0.0039
40 PRODUCT PHYSICAL CONSISTENCY ISSUE 21 0.0038
41 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 29 0.0037
42 RESPIRATORY DISORDER NEONATAL 6 0.0037
43 RESORPTION BONE INCREASED 3 0.0037
44 SEBORRHOEIC DERMATITIS 6 0.0036
45 PUSTULE 8 0.0034
46 SKIN ODOUR ABNORMAL 13 0.0033
47 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
48 POST-ACUTE COVID-19 SYNDROME 4 0.0032
49 VENOUS INJURY 3 0.0032
50 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
51 MEGACOLON 5 0.0032
52 SOLAR LENTIGO 3 0.0032
53 VASCULAR PAIN 3 0.0031
54 ANGLE CLOSURE GLAUCOMA 8 0.0031
55 RETINAL DEGENERATION 4 0.0031
56 WOUND SECRETION 12 0.0031
57 MULTI-ORGAN DISORDER 6 0.0030
58 LEFT VENTRICULAR DYSFUNCTION 20 0.0030
59 BEZOAR 4 0.0029
60 DISCHARGE 4 0.0029
61 CUTANEOUS VASCULITIS 10 0.0027
62 AORTIC DILATATION 3 0.0027
63 IDIOPATHIC INTRACRANIAL HYPERTENSION 6 0.0027
64 INFECTED SKIN ULCER 5 0.0026
65 DERMATITIS ACNEIFORM 16 0.0026
66 CHEMICAL BURN 3 0.0026
67 FOLATE DEFICIENCY 3 0.0026
68 FEBRILE INFECTION 3 0.0025
69 PROCTITIS 7 0.0025
70 COLON CANCER METASTATIC 4 0.0025
71 TOXIC SKIN ERUPTION 25 0.0025
72 CLOSTRIDIUM COLITIS 3 0.0025
73 POOR QUALITY DRUG ADMINISTERED 16 0.0025
74 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
75 VITAMIN B12 DECREASED 7 0.0024
76 XEROSIS 3 0.0024
77 LIMB MASS 5 0.0023
78 WISDOM TEETH REMOVAL 3 0.0023
79 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
80 MACULAR HOLE 3 0.0022
81 VULVOVAGINAL SWELLING 4 0.0022
82 MENINGITIS VIRAL 3 0.0022
83 VASCULAR PURPURA 3 0.0021
84 JOINT INSTABILITY 3 0.0021
85 INTERVERTEBRAL DISCITIS 4 0.0021
86 CATAPLEXY 3 0.0021
87 SELF ESTEEM DECREASED 5 0.0021
88 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
89 ORAL INFECTION 8 0.0020
90 TOXIC EPIDERMAL NECROLYSIS 31 0.0020
91 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
92 EPICONDYLITIS 3 0.0020
93 LOSS OF EMPLOYMENT 6 0.0020
94 DEPRESSIVE SYMPTOM 7 0.0020
95 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
96 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
97 ROSACEA 9 0.0019
98 PRE-EXISTING CONDITION IMPROVED 12 0.0019
99 ORTHOPNOEA 6 0.0019
100 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
101 SUBCUTANEOUS ABSCESS 9 0.0019
102 SPUTUM INCREASED 4 0.0018
103 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0018
104 TOOTH INJURY 8 0.0018
105 CLOSTRIDIUM TEST POSITIVE 4 0.0018
106 SLEEP APNOEA SYNDROME 34 0.0018
107 HEPATORENAL SYNDROME 3 0.0018
108 TYMPANIC MEMBRANE PERFORATION 3 0.0018
109 CEREBELLAR INFARCTION 3 0.0018
110 BILIARY DYSKINESIA 3 0.0018
111 HAEMATOCRIT INCREASED 4 0.0018
112 DRUG ERUPTION 31 0.0017
113 IMMUNE THROMBOCYTOPENIA 8 0.0017
114 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
115 EYELID DISORDER 4 0.0017
116 PAPULE 12 0.0017
117 SKIN TIGHTNESS 8 0.0017
118 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
119 FEAR OF DISEASE 3 0.0017
120 MIXED LIVER INJURY 5 0.0017
121 VULVOVAGINAL PAIN 8 0.0017
122 LYMPHADENITIS 4 0.0017
123 ABSCESS LIMB 7 0.0016
124 VULVOVAGINAL BURNING SENSATION 10 0.0016
125 DYSCHEZIA 5 0.0016
126 ERYSIPELAS 8 0.0016
127 SCAR 27 0.0016
128 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0016
129 DIVERTICULUM 11 0.0015
130 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
131 SMALL INTESTINAL HAEMORRHAGE 3 0.0015
132 RASH MACULO-PAPULAR 33 0.0015
133 APPLICATION SITE DRYNESS 5 0.0015
134 DERMATITIS PSORIASIFORM 3 0.0015
135 WOUND COMPLICATION 5 0.0015
136 RASH MORBILLIFORM 4 0.0014
137 FOLLICULITIS 15 0.0014
138 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
139 DEVICE CONNECTION ISSUE 3 0.0014
140 SCLERODERMA 5 0.0014
141 PSYCHIATRIC SYMPTOM 10 0.0014
142 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
143 NEURODERMATITIS 5 0.0013
144 ADENOCARCINOMA 3 0.0013
145 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
146 AUTOIMMUNE THYROIDITIS 5 0.0013
147 PARANASAL SINUS DISCOMFORT 5 0.0013
148 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
149 EOSINOPHILIA 23 0.0013
150 BRUXISM 7 0.0013
151 METHAEMOGLOBINAEMIA 3 0.0013
152 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
153 SKIN PAPILLOMA 5 0.0012
154 VITAMIN B12 DEFICIENCY 5 0.0012
155 BRONCHITIS CHRONIC 3 0.0012
156 BACTERIAL SEPSIS 4 0.0012
157 ARTHRITIS BACTERIAL 5 0.0012
158 STAPHYLOCOCCAL SEPSIS 6 0.0012
159 SKIN REACTION 17 0.0012
160 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
161 CLOSTRIDIAL INFECTION 4 0.0012
162 HYPERPYREXIA 5 0.0012
163 SHOULDER OPERATION 5 0.0012
164 HYPERTRANSAMINASAEMIA 8 0.0011
165 MELANOCYTIC NAEVUS 5 0.0011
166 NECROTISING FASCIITIS 4 0.0011
167 SKIN LESION 31 0.0011
168 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
169 SHOULDER ARTHROPLASTY 3 0.0011
170 APPLICATION SITE PAIN 24 0.0011
171 SEBORRHOEA 4 0.0011
172 EOSINOPHIL COUNT INCREASED 9 0.0011
173 ANAL HAEMORRHAGE 3 0.0011
174 FLANK PAIN 10 0.0011
175 PRODUCT PACKAGING ISSUE 10 0.0011
176 PRODUCT ODOUR ABNORMAL 11 0.0010
177 CYST 13 0.0010
178 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
179 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 57 0.0010
180 NECK INJURY 3 0.0010
181 PHARYNGEAL SWELLING 10 0.0010
182 PURPURA 9 0.0010
183 ATYPICAL PNEUMONIA 3 0.0010
184 FUNGAL SKIN INFECTION 4 0.0010
185 ENURESIS 4 0.0010
186 ENDOCARDITIS 5 0.0010
187 LARYNGEAL OEDEMA 6 0.0010
188 HYPERURICAEMIA 4 0.0010
189 SCREAMING 6 0.0009
190 DRUG SPECIFIC ANTIBODY PRESENT 6 0.0009
191 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
192 OESOPHAGITIS 10 0.0009
193 DEAFNESS NEUROSENSORY 3 0.0009
194 ONYCHOMYCOSIS 4 0.0009
195 TOOTH FRACTURE 10 0.0009
196 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
197 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
198 PLANTAR FASCIITIS 3 0.0009
199 BREAST MASS 6 0.0009
200 METASTASES TO SPINE 3 0.0009
201 SUSPECTED OFF LABEL USE 4 0.0009
202 PERIORBITAL SWELLING 5 0.0009
203 FURUNCLE 7 0.0009
204 PREMATURE DELIVERY 14 0.0009
205 MICTURITION DISORDER 3 0.0009
206 HANGOVER 3 0.0009
207 RENAL FAILURE ACUTE 36 0.0008
208 THERMAL BURN 6 0.0008
209 COLITIS MICROSCOPIC 4 0.0008
210 BURSITIS 10 0.0008
211 MAJOR DEPRESSION 6 0.0008
212 THROMBOCYTOSIS 3 0.0008
213 PRODUCT CONTAINER ISSUE 7 0.0008
214 NASAL POLYPS 4 0.0008
215 APPLICATION SITE BURN 4 0.0008
216 WOUND HAEMORRHAGE 3 0.0008
217 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
218 ABDOMINAL TENDERNESS 4 0.0008
219 HEPATIC STEATOSIS 15 0.0008
220 SKIN INFECTION 9 0.0008
221 VEIN DISORDER 4 0.0008
222 PROTEIN TOTAL DECREASED 3 0.0008
223 SNORING 3 0.0008
224 CHOLESTASIS 15 0.0008
225 SKIN ULCER 20 0.0008
226 SPINAL CORD COMPRESSION 3 0.0008
227 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
228 CHEILITIS 4 0.0007
229 DECUBITUS ULCER 6 0.0007
230 GINGIVAL BLEEDING 10 0.0007
231 ACUTE HEPATIC FAILURE 10 0.0007
232 ATELECTASIS 7 0.0007
233 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
234 FOOT DEFORMITY 8 0.0007
235 STEVENS-JOHNSON SYNDROME 16 0.0007
236 ATRIAL SEPTAL DEFECT 6 0.0007
237 PRODUCT LEAKAGE 4 0.0007
238 FISTULA 8 0.0007
239 BODY TEMPERATURE DECREASED 7 0.0007
240 LOCALISED INFECTION 17 0.0007
241 DERMATITIS CONTACT 8 0.0007
242 CHOLECYSTECTOMY 8 0.0007
243 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
244 SKIN SWELLING 6 0.0007
245 HYPERVENTILATION 4 0.0007
246 ABSCESS 11 0.0007
247 ECZEMA 36 0.0007
248 DIVERTICULUM INTESTINAL 3 0.0007
249 ACNE 52 0.0007
250 NAIL DISORDER 6 0.0007
251 FOOT FRACTURE 13 0.0007
252 PARONYCHIA 3 0.0007
253 PETECHIAE 7 0.0007
254 HAEMOLYTIC ANAEMIA 6 0.0007
255 PROTHROMBIN TIME PROLONGED 4 0.0007
256 IRON DEFICIENCY 3 0.0007
257 SINUS CONGESTION 9 0.0007
258 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
259 HEPATITIS CHOLESTATIC 4 0.0007
260 ACNE CYSTIC 2 0.0007
261 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
262 PATHOGEN RESISTANCE 6 0.0007
263 HAEMODYNAMIC INSTABILITY 5 0.0007
264 RETINAL DETACHMENT 6 0.0007
265 ANAPHYLACTIC REACTION 36 0.0007
266 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
267 FOOD ALLERGY 5 0.0006
268 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
269 RENAL FUNCTION TEST ABNORMAL 3 0.0006
270 APHTHOUS ULCER 5 0.0006
271 BIPOLAR DISORDER 7 0.0006
272 THERAPY PARTIAL RESPONDER 10 0.0006
273 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
274 SKIN ABRASION 3 0.0006
275 OBESITY 10 0.0006
276 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
277 CELLULITIS 31 0.0006
278 HORMONE LEVEL ABNORMAL 3 0.0006
279 ANHEDONIA 16 0.0006
280 HAIR DISORDER 5 0.0006
281 PROTEIN URINE PRESENT 3 0.0006
282 DERMATITIS EXFOLIATIVE 3 0.0006
283 BONE LOSS 9 0.0006
284 CHOLECYSTITIS CHRONIC 4 0.0006
285 HAEMODIALYSIS 5 0.0006
286 BACTERAEMIA 7 0.0006
287 RASH 257 0.0006
288 TOOTH ABSCESS 6 0.0006
289 LIMB INJURY 16 0.0006
290 BLISTER 33 0.0006
291 IMPAIRED GASTRIC EMPTYING 8 0.0006
292 PHLEBITIS 3 0.0006
293 SKIN HYPERPIGMENTATION 5 0.0006
294 ONYCHOCLASIS 4 0.0006
295 RASH PAPULAR 13 0.0006
296 BLOOD MAGNESIUM DECREASED 5 0.0006
297 HAIR GROWTH ABNORMAL 4 0.0006
298 DERMATITIS 12 0.0006
299 FUNGAL INFECTION 19 0.0006
300 SKIN DISORDER 19 0.0006
301 JOINT DISLOCATION 6 0.0006
302 HEPATOCELLULAR INJURY 8 0.0006
303 APPLICATION SITE IRRITATION 7 0.0006
304 BRONCHOSPASM 8 0.0006
305 FOOD POISONING 3 0.0006
306 FACIAL PAIN 5 0.0006
307 PARALYSIS 8 0.0006
308 ANAL INCONTINENCE 5 0.0006
309 ERYTHEMA OF EYELID 3 0.0006
310 TONGUE DISORDER 4 0.0006
311 RASH PUSTULAR 4 0.0005
312 DRUG RESISTANCE 14 0.0005
313 RASH MACULAR 19 0.0005
314 INCREASED TENDENCY TO BRUISE 5 0.0005
315 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
316 BURNING SENSATION 38 0.0005
317 COAGULOPATHY 9 0.0005
318 SKIN HAEMORRHAGE 8 0.0005
319 ARTHROPOD BITE 4 0.0005
320 NECROSIS 3 0.0005
321 SUNBURN 4 0.0005
322 BACTERIAL INFECTION 10 0.0005
323 FACE OEDEMA 9 0.0005
324 LACERATION 5 0.0005
325 PAROSMIA 4 0.0005
326 SEPTIC SHOCK 23 0.0005
327 TENDON PAIN 4 0.0005
328 SCAB 6 0.0005
329 MYOCARDITIS 6 0.0005
330 POST PROCEDURAL COMPLICATION 10 0.0005
331 ANGIOEDEMA 23 0.0005
332 ENTEROCOLITIS 3 0.0005
333 THROAT TIGHTNESS 14 0.0005
334 RALES 3 0.0005
335 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
336 POST PROCEDURAL HAEMORRHAGE 6 0.0005
337 VASCULITIS 6 0.0005
338 PRODUCT LABEL CONFUSION 3 0.0005
339 AUTOIMMUNE DISORDER 5 0.0005
340 HAEMORRHOIDS 10 0.0005
341 INFLAMMATORY BOWEL DISEASE 5 0.0005
342 POOR QUALITY SLEEP 11 0.0005
343 OSTEOPOROSIS 21 0.0005
344 LIP SWELLING 17 0.0005
345 DRUG-INDUCED LIVER INJURY 16 0.0005
346 TORSADE DE POINTES 4 0.0005
347 VITREOUS FLOATERS 5 0.0005
348 LYMPHADENOPATHY 18 0.0005
349 RESPIRATORY DISTRESS 14 0.0005
350 SINUS DISORDER 10 0.0005
351 HAEMATOCRIT DECREASED 10 0.0005
352 RENAL CYST 4 0.0005
353 ODYNOPHAGIA 3 0.0005
354 RASH ERYTHEMATOUS 24 0.0005
355 HEARING IMPAIRED 3 0.0005
356 LEUKOCYTOSIS 9 0.0005
357 SEASONAL ALLERGY 7 0.0005
358 TASTE DISORDER 10 0.0005
359 ERYTHEMA 101 0.0005
360 INTENTIONAL DOSE OMISSION 14 0.0005
361 RESPIRATORY DEPRESSION 6 0.0005
362 ABNORMAL FAECES 4 0.0005
363 HICCUPS 4 0.0005
364 DRY SKIN 65 0.0005
365 STAPHYLOCOCCAL INFECTION 16 0.0005
366 AGRANULOCYTOSIS 9 0.0005
367 NASAL DRYNESS 3 0.0005
368 PALLOR 13 0.0005
369 DERMATITIS ALLERGIC 6 0.0005
370 CANDIDA INFECTION 8 0.0005
371 HEPATIC CYTOLYSIS 6 0.0005
372 C-REACTIVE PROTEIN INCREASED 17 0.0005
373 PROCTALGIA 3 0.0005
374 WOUND 13 0.0005
375 PSYCHOLOGICAL TRAUMA 4 0.0005
376 MULTI-ORGAN FAILURE 8 0.0005
377 PYELONEPHRITIS 4 0.0005
378 SOMNAMBULISM 3 0.0005
379 DRUG INTOLERANCE 44 0.0005
380 IMMUNE SYSTEM DISORDER 6 0.0005
381 ANKYLOSING SPONDYLITIS 6 0.0005
382 DERMATITIS ATOPIC 24 0.0005
383 TOOTH INFECTION 6 0.0005
384 GASTROINTESTINAL PAIN 5 0.0005
385 ABDOMINAL ABSCESS 2 0.0005
386 DENTAL CARIES 5 0.0005
387 RESPIRATORY RATE INCREASED 4 0.0005
388 CONDITION AGGRAVATED 136 0.0004
389 QUALITY OF LIFE DECREASED 6 0.0004
390 MALNUTRITION 5 0.0004
391 INFLAMMATION 23 0.0004
392 COLITIS ISCHAEMIC 3 0.0004
393 OROPHARYNGEAL DISCOMFORT 4 0.0004
394 PNEUMOTHORAX 7 0.0004
395 ULCER 7 0.0004
396 RESTLESS LEGS SYNDROME 8 0.0004
397 PRODUCT USE IN UNAPPROVED INDICATION 109 0.0004
398 SKIN EXFOLIATION 37 0.0004
399 PRURITUS 168 0.0004
400 TINNITUS 20 0.0004
401 SHOCK 10 0.0004
402 PULMONARY EMBOLISM 41 0.0004
403 CONJUNCTIVITIS 8 0.0004
404 EYELID OEDEMA 5 0.0004
405 SWELLING FACE 28 0.0004
406 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
407 DEFAECATION URGENCY 3 0.0004
408 SUICIDAL IDEATION 39 0.0004
409 RASH GENERALISED 11 0.0004
410 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
411 URTICARIA 71 0.0004
412 SPUTUM DISCOLOURED 4 0.0004
413 DEAFNESS 11 0.0004
414 APPLICATION SITE ERYTHEMA 11 0.0004
415 FAECES DISCOLOURED 9 0.0004
416 SKIN IRRITATION 19 0.0004
417 DERMATITIS BULLOUS 3 0.0004
418 SCHIZOPHRENIA 5 0.0004
419 RESPIRATORY FAILURE 30 0.0004
420 TREATMENT FAILURE 34 0.0004
421 SURGERY 24 0.0004
422 SKIN FISSURES 8 0.0004
423 MELAENA 9 0.0004
424 GASTRIC DISORDER 14 0.0004
425 ENCEPHALOPATHY 10 0.0004
426 LIVER DISORDER 18 0.0004
427 TOOTH DISORDER 9 0.0004
428 LIGAMENT SPRAIN 4 0.0004
429 PHARYNGITIS 5 0.0004
430 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
431 HYPOTONIA 4 0.0004
432 POOR QUALITY DEVICE USED 4 0.0004
433 HAEMATOCHEZIA 22 0.0004
434 ACUTE KIDNEY INJURY 61 0.0004
435 STOMATITIS 24 0.0004
436 VAGINAL DISCHARGE 4 0.0004
437 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
438 AORTIC ANEURYSM 3 0.0004
439 TROPONIN INCREASED 3 0.0004
440 BONE MARROW FAILURE 8 0.0004
441 DIABETES MELLITUS 30 0.0004
442 MOTOR DYSFUNCTION 4 0.0004
443 GALLBLADDER DISORDER 7 0.0004
444 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
445 RENAL FAILURE CHRONIC 3 0.0004
446 ANAPHYLACTIC SHOCK 10 0.0004
447 OSTEOMYELITIS 7 0.0004
448 LUNG INFECTION 6 0.0004
449 HYPOALBUMINAEMIA 3 0.0004
450 APNOEA 3 0.0004
451 RED BLOOD CELL COUNT DECREASED 11 0.0004
452 SWOLLEN TONGUE 12 0.0004
453 TENDERNESS 4 0.0004
454 PULMONARY HAEMORRHAGE 3 0.0004
455 NODULE 5 0.0004
456 MUCOSAL INFLAMMATION 10 0.0004
457 ORAL CANDIDIASIS 5 0.0004
458 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
459 NASAL DISCOMFORT 3 0.0004
460 PLEURAL EFFUSION 23 0.0004
461 GINGIVAL PAIN 3 0.0004
462 ATRIAL FLUTTER 3 0.0004
463 BONE PAIN 22 0.0004
464 HEPATIC FUNCTION ABNORMAL 14 0.0004
465 SENSORY LOSS 3 0.0004
466 BLOOD SODIUM DECREASED 7 0.0004
467 HYPOXIA 13 0.0004
468 RASH PRURITIC 20 0.0004
469 POST PROCEDURAL INFECTION 3 0.0004
470 SHOCK HAEMORRHAGIC 3 0.0004
471 LIVER INJURY 9 0.0004
472 BLOOD POTASSIUM DECREASED 11 0.0004
473 PREMATURE BABY 11 0.0004
474 HYPERAESTHESIA 3 0.0004
475 RENAL DISORDER 17 0.0004
476 ESCHERICHIA INFECTION 3 0.0004
477 SPINAL COMPRESSION FRACTURE 3 0.0004
478 EMBOLISM 3 0.0004
479 PNEUMONIA ASPIRATION 9 0.0004
480 NERVE INJURY 4 0.0004
481 MATERNAL EXPOSURE DURING PREGNANCY 32 0.0004
482 URINARY TRACT INFECTION 61 0.0004
483 EYE PRURITUS 12 0.0004
484 SENSATION OF FOREIGN BODY 3 0.0004
485 SKIN PLAQUE 3 0.0004
486 HYPERSENSITIVITY 66 0.0004
487 EYE INFECTION 4 0.0004
488 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
489 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
490 INTERSTITIAL LUNG DISEASE 17 0.0004
491 VITAMIN D DECREASED 3 0.0004
492 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
493 ILLNESS 36 0.0003
494 ANURIA 3 0.0003
495 PARANOIA 6 0.0003
496 HYPOKALAEMIA 16 0.0003
497 HYSTERECTOMY 3 0.0003
498 PERICARDIAL EFFUSION 8 0.0003
499 RENAL IMPAIRMENT 29 0.0003
500 HYPERTENSION 73 0.0003
501 GASTRITIS 9 0.0003
502 METASTASES TO LIVER 6 0.0003
503 TUMOUR LYSIS SYNDROME 3 0.0003
504 ASCITES 10 0.0003
505 IMMUNOSUPPRESSION 3 0.0003
506 LEUKOPENIA 17 0.0003
507 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
508 INFECTION 49 0.0003
509 PULMONARY HYPERTENSION 7 0.0003
510 PULMONARY MASS 5 0.0003
511 MYOCLONUS 4 0.0003
512 JAUNDICE 9 0.0003
513 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
514 FREQUENT BOWEL MOVEMENTS 9 0.0003
515 TOOTHACHE 6 0.0003
516 LACRIMATION INCREASED 10 0.0003
517 PNEUMONITIS 9 0.0003
518 ARTHRITIS 26 0.0003
519 LIP DRY 3 0.0003
520 URINARY RETENTION 11 0.0003
521 PSORIASIS 43 0.0003
522 NEPHROLITHIASIS 15 0.0003
523 INSURANCE ISSUE 5 0.0003
524 IRRITABLE BOWEL SYNDROME 7 0.0003
525 RECTAL HAEMORRHAGE 14 0.0003
526 MUSCLE SPASTICITY 4 0.0003
527 UROSEPSIS 3 0.0003
528 NERVE COMPRESSION 3 0.0003
529 SPINAL OPERATION 4 0.0003
530 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
531 GENERALISED OEDEMA 4 0.0003
532 MUSCULOSKELETAL CHEST PAIN 5 0.0003
533 EYE SWELLING 12 0.0003
534 ERYTHEMA MULTIFORME 3 0.0003
535 HEPATIC ENCEPHALOPATHY 3 0.0003
536 APPENDICITIS 3 0.0003
537 SKIN BURNING SENSATION 23 0.0003
538 DIARRHOEA HAEMORRHAGIC 3 0.0003
539 DRY EYE 16 0.0003
540 INJECTION SITE DISCOLOURATION 4 0.0003
541 BRAIN FOG 5 0.0003
542 PHOTOPHOBIA 6 0.0003
543 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
544 HALLUCINATION, AUDITORY 5 0.0003
545 HEPATOTOXICITY 7 0.0003
546 PRODUCTIVE COUGH 15 0.0003
547 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
548 METABOLIC ACIDOSIS 10 0.0003
549 HEPATITIS 8 0.0003
550 PYREXIA 108 0.0003
551 MYDRIASIS 4 0.0003
552 VERTIGO 19 0.0003
553 RHABDOMYOLYSIS 13 0.0003
554 SENSORY DISTURBANCE 5 0.0003
555 PRODUCT QUALITY ISSUE 42 0.0003
556 DYSPHONIA 18 0.0003
557 BACK DISORDER 5 0.0003
558 ORAL HERPES 6 0.0003
559 COELIAC DISEASE 3 0.0003
560 SKIN DISCOLOURATION 14 0.0003
561 UNEVALUABLE EVENT 23 0.0003
562 HOSPICE CARE 3 0.0003
563 VENTRICULAR TACHYCARDIA 5 0.0003
564 ABDOMINAL PAIN UPPER 62 0.0003
565 EAR INFECTION 8 0.0003
566 VIRAL INFECTION 10 0.0003
567 FLATULENCE 17 0.0003
568 EYE HAEMORRHAGE 4 0.0003
569 DEPRESSION 68 0.0003
570 FULL BLOOD COUNT DECREASED 6 0.0003
571 EMPHYSEMA 3 0.0003
572 SEPSIS 33 0.0003
573 EYELID PTOSIS 3 0.0003
574 DIARRHOEA 190 0.0003
575 EPISTAXIS 22 0.0003
576 BODY TEMPERATURE INCREASED 6 0.0003
577 INITIAL INSOMNIA 3 0.0003
578 MUSCULOSKELETAL DISCOMFORT 5 0.0003
579 COLITIS 11 0.0003
580 HYPERBILIRUBINAEMIA 3 0.0003
581 VENTRICULAR EXTRASYSTOLES 3 0.0003
582 ORAL DISCOMFORT 4 0.0003
583 HYPOMAGNESAEMIA 4 0.0003
584 WEIGHT FLUCTUATION 3 0.0003
585 CEREBRAL INFARCTION 7 0.0003
586 PANCYTOPENIA 16 0.0003
587 NECK PAIN 16 0.0003
588 MASS 4 0.0003
589 HYPERKALAEMIA 10 0.0003
590 SCRATCH 3 0.0003
591 BLINDNESS UNILATERAL 4 0.0003
592 SUDDEN DEATH 3 0.0003
593 CHEST DISCOMFORT 29 0.0003
594 DRUG INEFFECTIVE 373 0.0003
595 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
596 ANXIETY 80 0.0003
597 BODY HEIGHT DECREASED 3 0.0003
598 HYPERSOMNIA 8 0.0003
599 CARDIOGENIC SHOCK 4 0.0003
600 RHINORRHOEA 18 0.0003
601 MOBILITY DECREASED 20 0.0003
602 IMPAIRED QUALITY OF LIFE 4 0.0003
603 LETHARGY 16 0.0003
604 DECREASED ACTIVITY 3 0.0003
605 DEHYDRATION 37 0.0003
606 PHARYNGITIS STREPTOCOCCAL 3 0.0003
607 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
608 SKIN LACERATION 3 0.0003
609 CARDIOVASCULAR DISORDER 7 0.0003
610 PELVIC PAIN 5 0.0003
611 FLUID OVERLOAD 4 0.0003
612 BLOOD PRESSURE INCREASED 42 0.0003
613 WOUND INFECTION 3 0.0003
614 OCULAR HYPERAEMIA 13 0.0003
615 COUGH 76 0.0003
616 TACHYCARDIA 24 0.0003
617 NEUTROPHIL COUNT DECREASED 11 0.0003
618 TRANSAMINASES INCREASED 6 0.0003
619 HYPERTENSIVE CRISIS 3 0.0003
620 RESPIRATORY TRACT INFECTION 7 0.0003
621 THROAT IRRITATION 12 0.0003
622 SWELLING 25 0.0003
623 EYE PAIN 15 0.0003
624 STATUS EPILEPTICUS 3 0.0003
625 ECONOMIC PROBLEM 4 0.0003
626 BLOOD COUNT ABNORMAL 4 0.0003
627 PRODUCT AVAILABILITY ISSUE 6 0.0003
628 PROTEINURIA 5 0.0003
629 PAIN 161 0.0003
630 ACIDOSIS 2 0.0003
631 DEEP VEIN THROMBOSIS 17 0.0003
632 OFF LABEL USE 229 0.0003
633 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
634 BLOOD CREATININE INCREASED 17 0.0003
635 MUSCLE TWITCHING 6 0.0003
636 PHARYNGEAL OEDEMA 4 0.0003
637 DRY MOUTH 21 0.0003
638 MADAROSIS 3 0.0003
639 FEMUR FRACTURE 8 0.0003
640 ABDOMINAL DISCOMFORT 43 0.0003
641 SPLENOMEGALY 3 0.0003
642 INJURY 18 0.0003
643 NASAL CONGESTION 15 0.0003
644 CYANOSIS 4 0.0003
645 DYSPEPSIA 25 0.0003
646 VAGINAL HAEMORRHAGE 11 0.0003
647 DYSPHAGIA 24 0.0003
648 BLOOD IRON DECREASED 3 0.0003
649 DIVERTICULITIS 7 0.0003
650 PRODUCT DOSE OMISSION ISSUE 74 0.0003
651 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
652 UPPER LIMB FRACTURE 5 0.0003
653 HAEMOPTYSIS 7 0.0003
654 THROMBOCYTOPENIA 28 0.0003
655 CARDIAC FAILURE CONGESTIVE 20 0.0002
656 HIP FRACTURE 8 0.0002
657 NIGHT SWEATS 8 0.0002
658 ASTHMA 28 0.0002
659 CHILLS 29 0.0002
660 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
661 FIBROMYALGIA 6 0.0002
662 FEEDING DISORDER 5 0.0002
663 PSORIATIC ARTHROPATHY 10 0.0002
664 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
665 IMPAIRED HEALING 8 0.0002
666 HAEMOGLOBIN DECREASED 25 0.0002
667 INJECTION SITE EXTRAVASATION 3 0.0002
668 HEART RATE INCREASED 24 0.0002
669 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
670 ILEUS 3 0.0002
671 INFUSION RELATED REACTION 16 0.0002
672 HAIR COLOUR CHANGES 3 0.0002
673 PNEUMONIA 78 0.0002
674 EXPIRED PRODUCT ADMINISTERED 8 0.0002
675 BRAIN OEDEMA 3 0.0002
676 MOUTH ULCERATION 5 0.0002
677 MUSCLE ATROPHY 3 0.0002
678 NAUSEA 186 0.0002
679 EATING DISORDER 5 0.0002
680 HEPATIC ENZYME INCREASED 16 0.0002
681 GASTROINTESTINAL DISORDER 21 0.0002
682 IMPAIRED WORK ABILITY 5 0.0002
683 FEELING ABNORMAL 56 0.0002
684 ROTATOR CUFF SYNDROME 3 0.0002
685 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
686 INFUSION SITE PAIN 3 0.0002
687 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
688 HEPATIC FAILURE 7 0.0002
689 DISEASE RECURRENCE 11 0.0002
690 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
691 DIPLOPIA 6 0.0002
692 OEDEMA PERIPHERAL 28 0.0002
693 ORTHOSTATIC HYPOTENSION 4 0.0002
694 DRUG ADMINISTRATION ERROR 7 0.0002
695 DRUG INTERACTION 36 0.0002
696 FEBRILE NEUTROPENIA 15 0.0002
697 HEAD DISCOMFORT 4 0.0002
698 WEIGHT DECREASED 63 0.0002
699 HAIR TEXTURE ABNORMAL 3 0.0002
700 ALOPECIA 44 0.0002
701 THIRST 4 0.0002
702 CEREBRAL HAEMORRHAGE 8 0.0002
703 PULMONARY OEDEMA 10 0.0002
704 SNEEZING 5 0.0002
705 GASTROENTERITIS VIRAL 4 0.0002
706 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
707 TACHYPNOEA 3 0.0002
708 BONE DISORDER 4 0.0002
709 CORONARY ARTERY OCCLUSION 3 0.0002
710 RESTLESSNESS 8 0.0002
711 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
712 APPLICATION SITE RASH 3 0.0002
713 FATIGUE 169 0.0002
714 PLATELET COUNT DECREASED 23 0.0002
715 CONSTIPATION 47 0.0002
716 JOINT SWELLING 26 0.0002
717 VOMITING 100 0.0002
718 SLEEP DISORDER 15 0.0002
719 MALAISE 93 0.0002
720 DISEASE PROGRESSION 25 0.0002
721 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
722 CHRONIC KIDNEY DISEASE 16 0.0002
723 GASTRIC ULCER 4 0.0002
724 MUSCULOSKELETAL DISORDER 4 0.0002
725 PRODUCT PRESCRIBING ERROR 5 0.0002
726 HERPES ZOSTER 12 0.0002
727 PULMONARY FIBROSIS 4 0.0002
728 DRUG PRESCRIBING ERROR 4 0.0002
729 PARAESTHESIA ORAL 3 0.0002
730 GLAUCOMA 4 0.0002
731 ANOSMIA 3 0.0002
732 HYPERTHYROIDISM 3 0.0002
733 HERNIA 4 0.0002
734 MENTAL IMPAIRMENT 5 0.0002
735 CARDIAC ARREST 17 0.0002
736 OROPHARYNGEAL PAIN 19 0.0002
737 CHOKING 4 0.0002
738 KIDNEY INFECTION 4 0.0002
739 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
740 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
741 DECREASED APPETITE 47 0.0002
742 DYSPNOEA 114 0.0002
743 COLON CANCER 3 0.0002
744 PREGNANCY 4 0.0002
745 IRRITABILITY 12 0.0002
746 HEART RATE DECREASED 7 0.0002
747 ANAEMIA 38 0.0002
748 PRODUCT PHYSICAL ISSUE 4 0.0002
749 PRODUCT ADMINISTRATION ERROR 4 0.0002
750 PRODUCT USE ISSUE 37 0.0002
751 BLINDNESS 8 0.0002
752 RENAL FAILURE 26 0.0002
753 SINUSITIS 20 0.0002
754 LOSS OF CONSCIOUSNESS 25 0.0002
755 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
756 RIB FRACTURE 4 0.0002
757 ANKLE FRACTURE 3 0.0002
758 DELUSION 3 0.0002
759 ACUTE MYELOID LEUKAEMIA 3 0.0002
760 DYSURIA 7 0.0002
761 ARTHRALGIA 79 0.0002
762 KNEE ARTHROPLASTY 4 0.0002
763 MIGRAINE 18 0.0002
764 CYSTITIS 6 0.0002
765 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
766 JOINT INJURY 4 0.0002
767 CARDIAC FAILURE 15 0.0002
768 HOT FLUSH 14 0.0002
769 PAIN OF SKIN 5 0.0002
770 WHEEZING 11 0.0002
771 MUSCLE TIGHTNESS 3 0.0002
772 BLOOD BILIRUBIN INCREASED 5 0.0002
773 PRURITUS GENERALISED 4 0.0002
774 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
775 PRODUCT PRESCRIBING ISSUE 4 0.0002
776 METASTASES TO BONE 3 0.0002
777 PHOTOSENSITIVITY REACTION 3 0.0002
778 THERAPEUTIC RESPONSE DECREASED 11 0.0002
779 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
780 HEADACHE 113 0.0002
781 FEELING COLD 5 0.0002
782 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
783 FEELING HOT 11 0.0002
784 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
785 CONTUSION 17 0.0002
786 PAIN IN EXTREMITY 52 0.0002
787 APPLICATION SITE PRURITUS 4 0.0002
788 CIRCULATORY COLLAPSE 3 0.0002
789 BRONCHITIS 13 0.0002
790 PERIPHERAL SWELLING 27 0.0002
791 HAEMATURIA 6 0.0002
792 ABORTION SPONTANEOUS 7 0.0002
793 ATRIAL FIBRILLATION 17 0.0002
794 EYE IRRITATION 10 0.0002
795 EMOTIONAL DISTRESS 21 0.0002
796 DELIRIUM 6 0.0002
797 CHEST PAIN 32 0.0002
798 DIZZINESS 86 0.0002
799 DYSKINESIA 7 0.0002
800 PALPITATIONS 20 0.0002
801 COLD SWEAT 3 0.0002
802 LABORATORY TEST ABNORMAL 5 0.0002
803 ARRHYTHMIA 8 0.0002
804 PRODUCT DOSE OMISSION 11 0.0002
805 CATARACT 10 0.0002
806 BACK PAIN 39 0.0002
807 VISION BLURRED 23 0.0002
808 ACCIDENT 2 0.0002
809 CARDIO-RESPIRATORY ARREST 7 0.0002
810 GOUT 3 0.0002
811 BLOOD PRESSURE FLUCTUATION 4 0.0002
812 OEDEMA 9 0.0002
813 APHASIA 5 0.0002
814 PANIC ATTACK 6 0.0002
815 NEURALGIA 4 0.0002
816 SEIZURE 19 0.0002
817 END STAGE RENAL DISEASE 3 0.0002
818 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
819 ACCIDENTAL OVERDOSE 6 0.0002
820 EPILEPSY 5 0.0002
821 AGITATION 12 0.0002
822 INJECTION SITE URTICARIA 4 0.0002
823 NASOPHARYNGITIS 30 0.0002
824 HAEMORRHAGE 17 0.0002
825 BLOOD GLUCOSE ABNORMAL 3 0.0002
826 INFLUENZA 18 0.0002
827 THINKING ABNORMAL 3 0.0002
828 OXYGEN SATURATION DECREASED 9 0.0002
829 HYPONATRAEMIA 9 0.0002
830 ASTHENIA 60 0.0002
831 HYPOTENSION 32 0.0002
832 DYSPNOEA EXERTIONAL 6 0.0002
833 ABDOMINAL PAIN 37 0.0002
834 BLOOD URINE PRESENT 3 0.0002
835 NEUROPATHY PERIPHERAL 15 0.0002
836 FEELING JITTERY 3 0.0002
837 HYPOPHAGIA 4 0.0002
838 ACUTE RESPIRATORY FAILURE 3 0.0002
839 THERAPY NON-RESPONDER 7 0.0002
840 UNRESPONSIVE TO STIMULI 4 0.0002
841 EAR PAIN 3 0.0002
842 ABDOMINAL DISTENSION 16 0.0002
843 NERVOUSNESS 8 0.0002
844 SPEECH DISORDER 8 0.0002
845 CHOLELITHIASIS 5 0.0002
846 DISABILITY 3 0.0002
847 SPINAL FRACTURE 3 0.0001
848 GAIT INABILITY 5 0.0001
849 CYTOKINE RELEASE SYNDROME 3 0.0001
850 THROMBOSIS 12 0.0001
851 TYPE 2 DIABETES MELLITUS 5 0.0001
852 FALL 49 0.0001
853 NEUTROPENIA 20 0.0001
854 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
855 SOMNOLENCE 29 0.0001
856 MEDICATION ERROR 8 0.0001
857 LUNG DISORDER 7 0.0001
858 PAIN IN JAW 4 0.0001
859 MUSCULAR WEAKNESS 16 0.0001
860 HYPOAESTHESIA 21 0.0001
861 ANGINA PECTORIS 4 0.0001
862 HYPOACUSIS 6 0.0001
863 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
864 ACCIDENTAL UNDERDOSE 2 0.0001
865 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
866 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
867 AMNESIA 9 0.0001
868 PRODUCT DISPENSING ERROR 3 0.0001
869 INJECTION SITE HAEMORRHAGE 11 0.0001
870 LIVER FUNCTION TEST ABNORMAL 4 0.0001
871 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
872 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
873 MUSCLE SPASMS 25 0.0001
874 CONFUSIONAL STATE 22 0.0001
875 BLOOD PRESSURE DECREASED 9 0.0001
876 PSYCHOTIC DISORDER 4 0.0001
877 URINARY INCONTINENCE 4 0.0001
878 INJECTION SITE PRURITUS 9 0.0001
879 GLOSSODYNIA 3 0.0001
880 ORAL PAIN 3 0.0001
881 RESPIRATORY DISORDER 4 0.0001
882 MUSCULOSKELETAL PAIN 7 0.0001
883 PANCREATITIS ACUTE 3 0.0001
884 DYSARTHRIA 5 0.0001
885 INTESTINAL OBSTRUCTION 5 0.0001
886 DEPRESSED MOOD 7 0.0001
887 DISCOMFORT 8 0.0001
888 GAIT DISTURBANCE 25 0.0001
889 INJECTION SITE PAIN 40 0.0001
890 SYNCOPE 13 0.0001
891 DISTURBANCE IN ATTENTION 7 0.0001
892 WEIGHT INCREASED 29 0.0001
893 LIMB DISCOMFORT 4 0.0001
894 FLUSHING 13 0.0001
895 INSOMNIA 34 0.0001
896 HEAD INJURY 4 0.0001
897 THERAPY INTERRUPTED 9 0.0001
898 HYPOTHYROIDISM 4 0.0001
899 HYPERHIDROSIS 16 0.0001
900 PRESYNCOPE 3 0.0001
901 CONVULSION 7 0.0001
902 EYE DISORDER 4 0.0001
903 ABASIA 3 0.0001
904 DYSGEUSIA 9 0.0001
905 VISUAL IMPAIRMENT 15 0.0001
906 TREMOR 20 0.0001
907 AGEUSIA 3 0.0001
908 AGGRESSION 6 0.0001
909 COVID-19 21 0.0001
910 ROAD TRAFFIC ACCIDENT 5 0.0001
911 ABDOMINAL PAIN LOWER 3 0.0001
912 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
913 HAEMATEMESIS 3 0.0001
914 FLUID RETENTION 6 0.0001
915 MYALGIA 20 0.0001
916 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
917 BLOOD GLUCOSE INCREASED 22 0.0001
918 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
919 HAEMATOMA 3 0.0001
920 NIGHTMARE 4 0.0001
921 MENTAL DISORDER 5 0.0001
922 INJECTION SITE BRUISING 9 0.0001
923 CEREBROVASCULAR ACCIDENT 19 0.0001
924 FEAR 3 0.0001
925 ADVERSE DRUG REACTION 10 0.0001
926 CRYING 4 0.0001
927 HYPERGLYCAEMIA 4 0.0001
928 TREATMENT NONCOMPLIANCE 6 0.0001
929 MEMORY IMPAIRMENT 15 0.0001
930 RESPIRATORY ARREST 3 0.0001
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
932 ARTHROPATHY 6 0.0001
933 COGNITIVE DISORDER 5 0.0001
934 TOXICITY TO VARIOUS AGENTS 18 0.0001
935 RHEUMATOID ARTHRITIS 12 0.0001
936 COMA 5 0.0001
937 NEOPLASM MALIGNANT 7 0.0001
938 INJECTION SITE SWELLING 8 0.0001
939 BALANCE DISORDER 9 0.0001
940 DYSSTASIA 3 0.0001
941 PLASMA CELL MYELOMA 4 0.0001
942 ABNORMAL BEHAVIOUR 4 0.0001
943 DEVICE ISSUE 9 0.0001
944 SUICIDE ATTEMPT 6 0.0001
945 EXTRA DOSE ADMINISTERED 4 0.0001
946 EMOTIONAL DISORDER 3 0.0001
947 GYNAECOMASTIA 3 0.0001
948 EXPOSURE DURING PREGNANCY 6 0.0001
949 NERVOUS SYSTEM DISORDER 3 0.0001
950 BRADYCARDIA 5 0.0001
951 MOOD SWINGS 3 0.0001
952 MOVEMENT DISORDER 3 0.0001
953 LACTIC ACIDOSIS 3 0.0001
954 DEVICE DISLOCATION 4 0.0001
955 INCORRECT DOSE ADMINISTERED 21 0.0001
956 PRODUCT STORAGE ERROR 8 0.0001
957 VISUAL ACUITY REDUCED 3 0.0001
958 ANGER 3 0.0001
959 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
960 COMPLETED SUICIDE 7 0.0001
961 MYELOSUPPRESSION 3 0.0001
962 INJECTION SITE ERYTHEMA 10 0.0001
963 MUSCULOSKELETAL STIFFNESS 7 0.0001
964 HALLUCINATION 6 0.0001
965 HOSPITALISATION 12 0.0001
966 PANCREATITIS 4 0.0001
967 DRUG EFFECT DECREASED 4 0.0001
968 DEVICE BREAKAGE 3 0.0001
969 INFLUENZA LIKE ILLNESS 6 0.0001
970 DRUG DOSE OMISSION 12 0.0001
971 ABNORMAL DREAMS 2 0.0001
972 NO ADVERSE EVENT 13 0.0001
973 PARAESTHESIA 11 0.0001
974 PRODUCT SUBSTITUTION ISSUE 4 0.0001
975 INTENTIONAL PRODUCT MISUSE 6 0.0001
976 ACUTE MYOCARDIAL INFARCTION 2 0.0001
977 ILL-DEFINED DISORDER 4 0.0001
978 OVERDOSE 14 0.0001
979 BLOOD CHOLESTEROL INCREASED 3 0.0001
980 RENAL CANCER 3 0.0001
981 HYPOGLYCAEMIA 3 0.0001
982 DEVICE DIFFICULT TO USE 4 0.0001
983 MYOCARDIAL INFARCTION 10 0.0001
984 DEATH 49 0.0001
985 UNDERDOSE 4 0.0001
986 CARDIAC DISORDER 5 0.0001
987 INJECTION SITE REACTION 3 0.0000
988 DEVICE MALFUNCTION 3 0.0000
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
990 DRUG DOSE OMISSION BY DEVICE 3 0.0000
991 DRUG WITHDRAWAL SYNDROME 3 0.0000
992 BREAST CANCER 3 0.0000
993 DRUG DEPENDENCE 4 0.0000